
Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter
Strategic expansion into longevity market creates near-term commercial opportunity alongside continued clinical advancement of JOTROLâ„¢ JOTROLâ„¢ development programs remain tariff-exempt; consumer longevity line on track with negligible cost exposure Jupiter …